Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550108 · ClinicalTrials.gov registry record · Phase 3
Management of Incidentally Discovered Pancreatic Cysts
A Phase 3 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00550108: Clinical Trial Phase 3 study, sponsored by Massachusetts General Hospital.
NCT00550108 is a Phase 3 study that was terminated before completion, run by Massachusetts General Hospital. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00550108, a Phase 3 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to determine the natural history of pancreatic cysts and to determine if these cysts can be effectively treated with a less invasive therapy (ethanol injection vs periodic imaging) rather than surgical resection
Interventions
- OTHER Ethanol lavage
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-10 |
| Est. Completion | 2012-10 |
| Phase | Phase 3 |
Why NCT00550108 stopped before completion
NCT00550108 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Ethanol lavage is the first listed.
NCT00550108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00550108 about?
NCT00550108 is a clinical study titled "Management of Incidentally Discovered Pancreatic Cysts". The purpose of this study is to determine the natural history of pancreatic cysts and to determine if these cysts can be effectively treated with a less invasive therapy (ethanol injection vs periodic imaging) rather than surgical resection
What is the current status of trial NCT00550108?
This trial is currently terminated. It is a Phase 3 study. The study started on 2007-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00550108?
The interventions under investigation include: Ethanol lavage (OTHER).
Who is sponsoring clinical trial NCT00550108?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia